Impact of antenatal selective serotonin reuptake inhibitor exposure on pregnancy outcomes in mice

American Journal of Obstetrics and Gynecology

Volumn 203, Issue 4, 2010, Pages 375.e1-375.e4

  Bauer, Samuel ^a   Monk, Catherine ^a   Ansorge, Mark ^a   Gyamfi, Cynthia ^a   Myers, Michael ^a  

^a Department of Neurology and the Taub Institute for Research on Alzheimer's Disease and the Aging Brain   (United States)

Author keywords

birth outcomes; mouse model; pregnancy; preterm birth; selective serotonin reuptake inhibitor

Indexed keywords

DRINKING WATER; FLUOXETINE; SEROTONIN UPTAKE INHIBITOR;

ADVERSE OUTCOME; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BIRTH RATE; BODY HEIGHT; BODY SIZE; CONTROLLED STUDY; EMBRYO; EXPERIMENTAL MOUSE; FEMALE; GESTATION PERIOD; LITTER SIZE; LIVE BIRTH; MARE; MOUSE; NIDATION; NONHUMAN; PREGNANCY COMPLICATION; PREGNANCY OUTCOME; PRENATAL DRUG EXPOSURE; PRIORITY JOURNAL; ANATOMY AND HISTOLOGY; ANIMAL; NEWBORN; PREGNANCY; PROSPECTIVE STUDY;

ANIMALS; ANIMALS, NEWBORN; BIRTH RATE; FEMALE; FLUOXETINE; LITTER SIZE; LIVE BIRTH; MICE; PREGNANCY; PROSPECTIVE STUDIES; SEROTONIN UPTAKE INHIBITORS;

EID: 77957372308     PISSN: 00029378     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.ajog.2010.05.008     Document Type: Article

References (32)

1. B.N. Gaynes, N. Gavin, and S. Meltzer-Brody Perinatal depression: prevalence, screening accuracy, and screening outcomes Evid Rep Technol Assess (Summ) 199 2005 1 8
2. American College of Obstetricians and Gynecologists Committee on Obstetric Practice ACOG committee opinion no. 354: treatment with selective serotonin reuptake inhibitors during pregnancy Obstet Gynecol 108 2006 1601 1603
3. M.K. Bakker, P. Kolling, P.B. van den Berg, H.E. de Walle, and L.T. de Jong van den Berg Increase in use of selective serotonin reuptake inhibitors in pregnancy during the last decade, a population-based cohort study from the Netherlands Br J Clin Pharmacol 65 2007 600 606
4. W.O. Cooper, M.E. Willy, S.J. Pont, and W.A. Ray Increasing use of antidepressants in pregnancy Am J Obstet Gynecol 196 2007 544.e1 544.e5
5. C.D. Chambers, S. Hernandez-Diaz, and L.J. Van Marter Selective serotonin-reuptake inhibitors and risk of persistent pulmonary hypertension of the newborn N Engl J Med 354 2006 579 587 (Pubitemid 43209105)
6. S. Alwan, J. Reefhuis, S.A. Rasmussen, R.S. Olney, and J.M. Friedman National birth defects prevention study: use of selective serotonin-reuptake inhibitors in pregnancy and the risk of birth defects N Engl J Med 356 2007 2684 2692
7. C. Louik, A.E. Lin, M.M. Werler, S. Hernndez-Daz, and A.A. Mitchell First-trimester use of selective serotonin-reuptake inhibitors and the risk of birth defects N Engl J Med 356 2007 2675 2683
8. B.E. Hamilton, J.A. Martin, and S.J. Ventura Births: preliminary data for 2005 Natl Vital Stat Rep 55 2006 1 18
9. R. Suri, L. Altshuler, G. Hellemann, V.K. Burt, A. Aquino, and J. Mintz Effects of antenatal depression and antidepressant treatment on gestational age at birth and risk of preterm birth Am J Psychiatry 164 2007 1206 1213
10. T.F. Oberlander, W. Warburton, S. Misri, J. Aghajanian, and C. Hertzman Neonatal outcomes after prenatal exposure to selective serotonin reuptake inhibitor antidepressants and maternal depression using population-based linked health data Arch Gen Psychiatry 63 2006 898 906
11. S. Wen, Q. Yang, and P. Garner Selective serotonin reuptake inhibitors and adverse pregnancy outcomes J Obstet Gynecol 194 2006 961 966
12. P.S. Zeskind, and L.E. Stephens Maternal selective serotonin reuptake inhibitor use during pregnancy and newborn neurobehavior Pediatrics 113 2004 368 375
13. G.E. Simon, M.L. Cunningham, and R.L. Davis Outcomes of prenatal antidepressant exposure Am J Psychiatry 159 2002 2055 2061
14. A.M. Costei, E. Kozer, T. Ho, S. Ito, and G. Koren Perinatal outcome following third trimester exposure to paroxetine Arch Pediatr Adolesc Med 156 2002 1129 1132
15. C.D. Chambers, K.A. Johnson, L.M. Dick, R.J. Felix, and K.L. Jones Birth outcomes in pregnant women taking fluoxetine N Engl J Med 335 1996 1010 1015
16. H. Malm, T. Klaukka, and P.J. Neuvonen Risks associated with selective serotonin reuptake inhibitors in pregnancy Obstet Gynecol 106 2005 1289 1296
17. R. Rahimi, S. Nikfar, and M. Abdollahi Pregnancy outcomes following exposure to serotonin reuptake inhibitors: a meta-analysis of clinical trials Reprod Toxicol 22 2006 571 575
18. M.E. Hemels, A. Einarson, G. Koren, K.L. Lanctt, and T.R. Einarson Antidepressant use during pregnancy and the rates of spontaneous abortions: a meta-analysis Ann Pharmacother 39 2005 803 809
19. L. Santarelli, M. Saxe, and C. Cross Requirement of hippocampal neurogenesis for the behavioral effects of antidepressants Science 301 2003 305 309
20. M.S. Ansorge, E. Morelli, and J.A. Gingrich Inhibition of serotonin but not norepinephrine transport during development produces delayed, persistent perturbations of emotional behaviors in mice J Neurosci 28 2008 199 207
21. K.L. Bairy, S. Madhyastha, K.P. Ashok, I. Bairy, and S. Malini Developmental and behavioral consequences of prenatal fluoxetine Pharmacology 79 2007 1 11
22. A. Heils, A. Teufel, and S. Petri Allelic variation of human serotonin transporter gene expression J Neurochem 66 1996 2621 2624
23. J. Rampono, S. Proud, L.P. Hackett, J.H. Kristensen, and K.F. Ilett A pilot study of newer antidepressant concentrations in cord and maternal serum and possible effects in the neonate Int J Neuropsychopharmacol 7 2004 329 334
24. C.J. Hobel Stress and preterm birth Clin Obstet Gynecol 47 2004 856 880
25. J. Belik Fetal and neonatal effects of maternal drug treatment for depression Semin Perinatol 32 2008 350 354
26. R. Suri, G. Hellemann, L. Cohen, A. Aquino, and L. Altshuler Saliva estriol levels in women with and without prenatal antidepressant treatment Biol Psychiatry 64 2008 533 537
27. R.P. Heine, J.A. McGregor, and T.M. Goodwin Serial salivary estriol to detect an increased risk of preterm birth Obstet Gynecol 96 2000 490 497
28. B. Lundy, N.A. Jones, and T. Field Prenatal depression effects on neonates Infant Behav Dev 22 1999 119 129
29. J.L. Morrison, C. Chien, K.W. Riggs, N. Gruber, and D. Rurak Effect of maternal fluoxetine administration on uterine blood flow, fetal blood gas status, and growth Pediatr Res 51 2002 433 442
30. C.W. Noorlander, F.F. Ververs, P.G. Nikkels, C. van Echteld, G. Visser, and M.P. Smidt Modulation of serotonin transporter function during fetal development causes dilated heart cardiomyopathy and lifeline behavioral abnormalities PLoS One 3 2008 e2782
31. A.M. Carter Animal models of human placentationa review Placenta 28 2007 S41 S47
32. R. Pijnenborg, L. Vercruysse, and M. Hanssens The uterine spiral arteries in human pregnancy: facts and controversies Placenta 27 2006 939 958